Anishiya Abrol > Hogan Lovells US LLP > Washington DC, United States > Lawyer Profile

Hogan Lovells US LLP
COLUMBIA SQUARE
555 THIRTEENTH STREET, NW
WASHINGTON DC 20004
DISTRICT OF COLUMBIA
United States

Work Department

Intellectual Property

Position

Counsel

Career

Anishiya Abrol supports companies in their development and commercialization of cutting-edge medical therapies and tools. She advises on and negotiates a variety of strategic transactions from collaborations to in-licensing and out-licensing to maximize intellectual property assets, and then assists the company in implementing and integrating the new assets.

Anishiya has been seconded to multiple life sciences companies. She knows the issues facing in-house counsel and works closely with members of the firm’s Regulatory and Privacy Practice groups to provide integrated and practical advice.

Anishiya’s practice encompasses the full life sciences life cycle, from the discovery in the lab to dispensing to a patient. She has an undergraduate science degree, and her curious nature draws her towards early stage research and development transactions and activities, including clinical trial agreements, material transfer agreements, contract research organization (CRO) agreements, core lab agreements, sponsored research, grants, and technology transfers, both domestically and internationally. Recognizing though that a therapy’s primary value lies in the hands of patients, she assists commercialization efforts with support on distribution agreements, specialty pharmacy agreements, co-promotion agreements, authorized generic agreements, out-licensing arrangements, and other similar commercial activities.

Languages

English

Memberships

Chair, Wills for Heroes Program, Virginia Bar Association (2008-2013)
Member, American Health Law Association
Member, Virginia Bar Association

Education

J.D., George Mason University School of Law, magna cum laude, 2004
B.A. Biology, University of Virginia, 1997
B.A. History, University of Virginia, 1997

Lawyer Rankings

United States > Healthcare > Life sciences

(Next Generation Partners)

Anishiya AbrolHogan Lovells US LLP

Hogan Lovells US LLP fields a deep litigation bench with expertise in the life sciences, strengthened by the October 2023 arrivals from Dechert LLP of patent litigators Howard Levine in Washington DC and Jennifer Swan in Silicon Valley, both of whom have experience in Hatch-Waxman disputes. On the non-contentious front, the practice supports major players in the pharmaceutical sector with their patent protection strategies, and is also noted for its work navigating the FDA approvals process. Leadership of the overarching practice is split between Philadelphia-based Steve Abrams, who handles IPOs and M&As in the sector, and Washington DC’s Lynn Mehler, who guides drug and biologics developers through the FDA approvals process; FDA approvals are also the key area of focus for Randy Prebula, also based in the capital. In Denver, Jodi Scott advises medical device manufacturers on MDRs and FDA inspections, while Washington’s David Fox tackles Hatch-Waxman litigation as it relates to generic drug production. Product liability litigation is the domain of Baltimore’s Lauren Colton, who represents clients facing MDLs and class actions, while Cullen Taylor and Anishiya Abrol, based in Virginia and Washington respectively, as supporting clients with the protection of their drug and medical devices patent portfolios and licensing transactions. Houston’s Andrew Strong is well versed in assisting early stage companies with growth strategies, financing and mergers.